Welcome

The Mississippi Society of Oncology was formed in 1991 for the purpose of promoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.

In addition,  the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.

And finally the MOS  acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.

____________________________________________________________

Announcements

Breaking: Major Changes to Part B Proposed by Trump Administration

Yesterday, the Trump Administration unveiled a sweeping proposal to overhaul Medicare Part B payment as part of efforts to address the high and unsustainable prices of prescription drugs in the U.S.

The proposal would set Part B payments based on the discounts manufacturers offer in other countries. Participation would cover 50 percent of the country and be mandatory in randomized geographic regions.

The proposal is still in a very early stage of advanced notice - this is essentially a request for comment before HHS begins extensive work drafting a formal proposal - and many questions and details remain unanswered.


ASCO has announced fifteen distinguished members selected by the Nominating Committee as candidates for open leadership positions within the Society. From November 1 to December 3, 2018, eligible ASCO members are encouraged to vote to choose new leaders and on proposed amendments to the ASCO Bylaws. To learn more about the candidates, click here and log into your ASCO account.

CMS Releases Physician Fee Schedule Final Rule

Yesterday, the Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy. Please see below for a summary of the changes in the final rule.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule

On Friday, the Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous.

Click here for the report.

Webinar: 2019 Medicare Reimbursement -- Final Rules Update

The Centers for Medicare and Medicaid Services recently published the final rules for 2019 Medicare reimbursement. ASCO is hosting a webinar to outline the rules and explain changes on December 5, 2018 from 4:00 – 5:00 PM Eastern. Please register now and encourage your members to do the same.

News

Quality Payment Program: 2018 CME Modules, Infographics, and Scoring Guide

The Centers for Medicare & Medicaid Services (CMS) posted three new Continuing Medical Education (CME) modules on the Medicare Learning Network Learning Management System for the 2018 Merit-based Incentive Payment System (MIPS):

  • Improvement Activities Performance Category: Basics, including reporting requirements, scoring, and flexibilities for small and rural practices
  • Cost Performance Category: Overview and how CMS calculates scores
  • Alternative Payment Model (APM): Overview, scoring standard, and reporting requirements for participants

Please inform your members that they can receive credit for learning how to participate in QPP. For more information, contact the Quality Payment Program at QPP@cms.hhs.gov.

AMA House of Delegates Adopts ASCO Resolutions on Step Therapy, Medicare Part B

The American Medical Association’s (AMA) House of Delegates (HOD) adopted and reaffirmed ASCO-led resolutions on cancer policy priorities, including step therapy, Medicare Part B drugs, a Competitive Acquisition Program (CAP), and clinical trial access during the recent Interim Meeting of the AMA HOD. Read more on ASCO in Action.




© 2008-2018  Mississippi Oncology Society.
All rights reserved | Phone: 601-909-3036

Powered by Wild Apricot Membership Software